Cargando…

Tocilizumab for treatment of patients with severe COVID–19: A retrospective cohort study

BACKGROUND: Tocilizumab was approved for chimeric antigen receptor T–cell therapy induced cytokine release syndrome and it may provide clinical benefit for selected COVID–19 patients. METHODS: In this retrospective cohort study, we analyzed hypoxic COVID–19 patients who were consecutively admitted b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kewan, Tariq, Covut, Fahrettin, Al–Jaghbeer, Mohammed J., Rose, Lori, Gopalakrishna, K.V., Akbik, Bassel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305505/ https://www.ncbi.nlm.nih.gov/pubmed/32766537 http://dx.doi.org/10.1016/j.eclinm.2020.100418

Ejemplares similares

Simultaneous Presentation of Waldenström's Macroglobulinemia and MYD88 Gene Mutation with Multiple Myeloma
por: Awada, Hassan, et al.
Publicado: (2019)

Hand-foot Syndrome Secondary to Low-dose Docetaxel in a Breast Cancer Patient
por: Kewan, Tariq, et al.
Publicado: (2019)

Late Central Nervous System Relapse in a Patient with Maxillary Sinus Lymphoma
por: Kewan, Tariq, et al.
Publicado: (2018)

Clinical Characteristics and Outcomes of Primary Breast Lymphoma: The Cleveland Clinic Experience
por: Kewan, Tariq, et al.
Publicado: (2020)

A Rare Case of ST-elevation Myocardial Infarction After Blunt Chest Trauma
por: Perez, Oscar, et al.
Publicado: (2020)

Transaminases are Potential Biomarkers of Disease Severity in COVID-19 Patients: A Single-Center Experience
por: Chadalavada, Pravallika, et al.
Publicado: (2020)

Inflammation characteristics and anti-inflammation treatment with tocilizumab of severe/critical COVID-19 patients: A retrospective cohort study
por: Hu, Qin, et al.
Publicado: (2021)

Characteristics and outcomes of adverse events after COVID‐19 vaccination
por: Kewan, Tariq, et al.
Publicado: (2021)

Tocilizumab in patients with severe COVID-19: a retrospective cohort study
por: Guaraldi, Giovanni, et al.
Publicado: (2020)

Spontaneous echo contrast in venous ultrasound of severe COVID-19 patients
por: Dugar, Siddharth, et al.
Publicado: (2020)

Comparison of anakinra and tocilizumab in management of severe COVID-19: a retrospective cohort study
por: KÜÇÜKŞAHİN, Orhan, et al.
Publicado: (2022)

Subcutaneous tocilizumab treatment in patients with severe COVID-19–related cytokine release syndrome: An observational cohort study
por: Mastroianni, Antonio, et al.
Publicado: (2020)

A Complicated Case of Posterior Reversible Encephalopathy Syndrome (PRES) Secondary to Severe Hypercalcemia
por: Alqaisi, Sura, et al.
Publicado: (2021)

551. Remdesivir and Tocilizumab for the Treatment of Severe COVID-19 in a Community Hospital: A Retrospective Cohort Study
por: Rodriguez-Nava, Guillermo, et al.
Publicado: (2021)

Safety and Efficacy of Tocilizumab in the Treatment of Severe Acute Respiratory Syndrome Coronavirus-2 Pneumonia: A Retrospective Cohort Study
por: Patel, Atul, et al.
Publicado: (2020)

Efficacy of the early treatment with tocilizumab-hydroxychloroquine and tocilizumab-remdesivir in severe COVID-19 Patients
por: Sarhan, Rania M., et al.
Publicado: (2022)

Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls
por: Mert, Ali, et al.
Publicado: (2021)

Tocilizumab is recommended for the treatment of severe COVID-19
por: Zhou, Yonggang, et al.
Publicado: (2020)

Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study
por: Campochiaro, Corrado, et al.
Publicado: (2020)

Early Use of Tocilizumab May Prevent Clinical Deterioration in Select COVID-19 Patients: A Case Series
por: Hitawala, Asif, et al.
Publicado: (2020)

Evaluation of the United Kingdom‐primary biliary cholangitis and global primary biliary cholangitis group prognostic models for primary biliary cholangitis patients treated with ursodeoxycholic acid in the U.S. population
por: Alomari, Mohammad, et al.
Publicado: (2019)

Matched cohort study on the efficacy of tocilizumab in patients with COVID-19
por: Rodríguez-Molinero, Alejandro, et al.
Publicado: (2021)

Left Internal Mammary Artery Transection: A Rare Complication of Pericardiocentesis
por: Nair, Raunak, et al.
Publicado: (2020)

Extracorporeal Membrane Oxygenation in Postcardiotomy Cardiogenic Shock
por: Akbik, Bassel, et al.
Publicado: (2023)

Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID-19 pneumonia and moderate hyperinflammation. A retrospective cohort study
por: Aomar-Millán, Ismael Francisco, et al.
Publicado: (2021)

Factors Influencing Disease Stability and Response to Tocilizumab Therapy in Severe COVID-19: A Retrospective Cohort Study
por: Hafez, Wael, et al.
Publicado: (2022)

Tocilizumab for the Treatment of COVID-19 Among Hospitalized Patients: A Matched Retrospective Cohort Analysis
por: Ignatius, Elisa H, et al.
Publicado: (2020)

Effect of Tocilizumab Treatment on Patients with Coronavirus Disease 2019 and Bacteremia: A Retrospective Cohort Study
por: Kuwahara, Masaatsu, et al.
Publicado: (2022)

Comparative Efficacy of Tocilizumab and Baricitinib Administration in COVID-19 Treatment: A Retrospective Cohort Study
por: Kojima, Yuichi, et al.
Publicado: (2022)

Effective treatment of severe COVID-19 patients with tocilizumab
por: Xu, Xiaoling, et al.
Publicado: (2020)

Tocilizumab, an Exploratory Treatment for Severe COVID-19 Patients
por: Wang, Yong, et al.
Publicado: (2022)

Tocilizumab in severe COVID-19
por: Lucio Liberato, Nicola, et al.
Publicado: (2020)

Blood transfusion for upper gastrointestinal bleeding: is less more again?
por: Al-Jaghbeer, Mohammed, et al.
Publicado: (2013)

562. Tocilizumab for the Treatment of Severe COVID-19: A Retrospective, Multi-Center, Case-Matched Series
por: Norman, Sarah, et al.
Publicado: (2020)

Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID‑19 pneumonia and moderate hyperinflammation. A retrospective cohort study: comment
por: Yurttutan, Sadık, et al.
Publicado: (2021)

Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID‑19 pneumonia and moderate hyperinflammation. A retrospective cohort study: reply
por: Aomar-Millán, Ismael Francisco, et al.
Publicado: (2021)

Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: A retrospective cohort study
por: Moreno-Pérez, Oscar, et al.
Publicado: (2020)

Early use of low dose tocilizumab in patients with COVID-19: A retrospective cohort study with a complete follow-up
por: De Rossi, Nicola, et al.
Publicado: (2020)

Tocilizumab in the treatment of critical COVID-19 pneumonia: A retrospective cohort study of mechanically ventilated patients
por: Fisher, Matthew J., et al.
Publicado: (2021)

Tocilizumab and Thromboembolism in COVID-19: A Retrospective Hospital-Based Cohort Analysis
por: Chan, Kok Hoe, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cv8oii4kdq3r4luc0dqcip8elu